Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's IMPORT SEIZURE AUTHORITY CHALLENGED

This article was originally published in The Gray Sheet

Executive Summary

FDA's IMPORT SEIZURE AUTHORITY CHALLENGED in an April 18 decision by a New Orleans federal judge that FDA was required to give an importer the opportunity to export mushrooms thought to be misbranded or adulterated before seizing them. The decision could impact on other FDA-regulated products such as devices, drugs and cosmetics.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002299

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel